Charts BriaCell Therapeutics Corp. Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 07/08/2026 BST			5-day change	1st Jan Change
3.640 ^USD	+5.51%		+5.81%	-48.80%

08-05	BriaCell Gets FDA Approval to Start Phase 1/2a of Prostate Cancer Immunotherapy Study	MT
08-05	Briacell Therapeutics Corp Receives Fda Clearance to Initiate Bria-Pros+ Clinical Study in Prostate Cancer	CI

ProRealTime Chart